RS51136B - Supstituisani pirolopiridini, kompozicije koje ih sadrže, postupak za njihovo dobijanje i upotreba - Google Patents
Supstituisani pirolopiridini, kompozicije koje ih sadrže, postupak za njihovo dobijanje i upotrebaInfo
- Publication number
- RS51136B RS51136B RSP-2009/0400A RSP20090400A RS51136B RS 51136 B RS51136 B RS 51136B RS P20090400 A RSP20090400 A RS P20090400A RS 51136 B RS51136 B RS 51136B
- Authority
- RS
- Serbia
- Prior art keywords
- pyridines
- producing
- composition containing
- substituted pyrrolo
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Proizvodi formule (I):gde:1) A i Ar su supstituisane fenil grupe; 2)L je NH-CO-NH;3) W je C(R6), jedan od Y i Z je odabran od N i NO, a drugi je C(R5);4) R1, R5, i R6 su H;5) Ra je H.Prijava sadrži još 17 patentnih zahteva.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0504173A FR2884821B1 (fr) | 2005-04-26 | 2005-04-26 | Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation |
| PCT/FR2006/000925 WO2006114520A2 (fr) | 2005-04-26 | 2006-04-26 | Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS51136B true RS51136B (sr) | 2010-10-31 |
Family
ID=35517344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RSP-2009/0400A RS51136B (sr) | 2005-04-26 | 2006-04-26 | Supstituisani pirolopiridini, kompozicije koje ih sadrže, postupak za njihovo dobijanje i upotreba |
Country Status (33)
| Country | Link |
|---|---|
| US (1) | US7947706B2 (sr) |
| EP (1) | EP1877409B1 (sr) |
| JP (1) | JP2008539211A (sr) |
| KR (1) | KR20080007229A (sr) |
| CN (1) | CN101166739A (sr) |
| AR (1) | AR061386A1 (sr) |
| AT (1) | ATE433976T1 (sr) |
| AU (1) | AU2006239105A1 (sr) |
| BR (1) | BRPI0613161A2 (sr) |
| CA (1) | CA2605744A1 (sr) |
| CR (1) | CR9463A (sr) |
| CY (1) | CY1109369T1 (sr) |
| DE (1) | DE602006007337D1 (sr) |
| DK (1) | DK1877409T3 (sr) |
| DO (1) | DOP2006000096A (sr) |
| EA (1) | EA012983B1 (sr) |
| ES (1) | ES2328629T3 (sr) |
| FR (1) | FR2884821B1 (sr) |
| GT (1) | GT200600174A (sr) |
| HR (1) | HRP20090494T1 (sr) |
| IL (1) | IL186523A0 (sr) |
| MA (1) | MA29480B1 (sr) |
| MX (1) | MX2007013084A (sr) |
| NO (1) | NO20075918L (sr) |
| PA (1) | PA8671301A1 (sr) |
| PE (1) | PE20071420A1 (sr) |
| PL (1) | PL1877409T3 (sr) |
| PT (1) | PT1877409E (sr) |
| RS (1) | RS51136B (sr) |
| SI (1) | SI1877409T1 (sr) |
| TN (1) | TNSN07360A1 (sr) |
| TW (1) | TW200718701A (sr) |
| WO (1) | WO2006114520A2 (sr) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8119655B2 (en) | 2005-10-07 | 2012-02-21 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
| JP2010505961A (ja) * | 2006-10-09 | 2010-02-25 | タケダ サン ディエゴ インコーポレイテッド | キナーゼ阻害剤 |
| GEP20135728B (en) | 2006-10-09 | 2013-01-25 | Takeda Pharmaceuticals Co | Kinase inhibitors |
| WO2008063888A2 (en) | 2006-11-22 | 2008-05-29 | Plexxikon, Inc. | Compounds modulating c-fms and/or c-kit activity and uses therefor |
| EP2121687B1 (en) | 2006-12-22 | 2015-10-14 | Astex Therapeutics Limited | Tricyclic amine derivatives as protein tyrosine kinase inhibitors |
| MX2009006706A (es) * | 2006-12-22 | 2009-07-02 | Astex Therapeutics Ltd | Compuestos heterociclicos biciclicos como inhibidores del receptor del factor de crecimiento de fibroblastos. |
| SG183036A1 (en) | 2007-07-17 | 2012-08-30 | Plexxikon Inc | Compounds and methods for kinase modulation, and indications therefor |
| GB0720038D0 (en) | 2007-10-12 | 2007-11-21 | Astex Therapeutics Ltd | New compounds |
| GB0720041D0 (en) | 2007-10-12 | 2007-11-21 | Astex Therapeutics Ltd | New Compounds |
| GB0810902D0 (en) | 2008-06-13 | 2008-07-23 | Astex Therapeutics Ltd | New compounds |
| DE102008052943A1 (de) | 2008-10-23 | 2010-04-29 | Merck Patent Gmbh | Azaindolderivate |
| CN105237530A (zh) | 2009-04-03 | 2016-01-13 | 豪夫迈罗氏公司 | 丙烷-1-磺酸{3-[5-(4-氯-苯基)-1H-吡咯并[2,3-b]吡啶-3-羰基]-2,4-二氟-苯基}-酰胺组合物及其用途 |
| GB0906472D0 (en) | 2009-04-15 | 2009-05-20 | Astex Therapeutics Ltd | New compounds |
| GB0906470D0 (en) | 2009-04-15 | 2009-05-20 | Astex Therapeutics Ltd | New compounds |
| US20110030037A1 (en) * | 2009-07-07 | 2011-02-03 | Vadim Olshansky | Zone migration in network access |
| US8329724B2 (en) | 2009-08-03 | 2012-12-11 | Hoffmann-La Roche Inc. | Process for the manufacture of pharmaceutically active compounds |
| KR20120102669A (ko) | 2009-11-06 | 2012-09-18 | 플렉시콘, 인코퍼레이티드 | 키나제 조정을 위한 화합물 및 방법, 및 이를 위한 적응증 |
| WO2012109075A1 (en) | 2011-02-07 | 2012-08-16 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
| TWI558702B (zh) | 2011-02-21 | 2016-11-21 | 普雷辛肯公司 | 醫藥活性物質的固態形式 |
| WO2013181075A1 (en) * | 2012-05-29 | 2013-12-05 | Merck Sharp & Dohme Corp. | Isotopically labeled biaryl urea compounds |
| US9150570B2 (en) | 2012-05-31 | 2015-10-06 | Plexxikon Inc. | Synthesis of heterocyclic compounds |
| US20140275082A1 (en) | 2013-03-14 | 2014-09-18 | Abbvie Inc. | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| GB201310460D0 (en) * | 2013-06-12 | 2013-07-24 | Lytix Biopharma As | Compounds |
| GB201310464D0 (en) * | 2013-06-12 | 2013-07-24 | Lytix Biopharma As | Compounds |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3254843B2 (ja) * | 1993-08-09 | 2002-02-12 | 三菱ウェルファーマ株式会社 | 新規縮合ヘテロ環誘導体 |
| US6335342B1 (en) * | 2000-06-19 | 2002-01-01 | Pharmacia & Upjohn S.P.A. | Azaindole derivatives, process for their preparation, and their use as antitumor agents |
| GB0115109D0 (en) * | 2001-06-21 | 2001-08-15 | Aventis Pharma Ltd | Chemical compounds |
| AU2002333524A1 (en) * | 2001-09-11 | 2003-03-24 | Glaxosmithkline K.K. | Furo-and thienopyrimidine derivatives as angiogenesis inhibitors |
| WO2003028724A1 (en) * | 2001-10-04 | 2003-04-10 | Smithkline Beecham Corporation | Chk1 kinase inhibitors |
| JP4623962B2 (ja) * | 2001-10-22 | 2011-02-02 | ザ・リサーチ・ファウンデーション・オブ・ステイト・ユニバーシティ・オブ・ニューヨーク | タンパク質キナーゼおよびホスファターゼ阻害剤、それらを設計する方法、ならびにそれらを使用する方法 |
| US7534800B2 (en) * | 2002-03-28 | 2009-05-19 | Eisai R & D Development Co., Ltd. | 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders |
| FR2878849B1 (fr) * | 2004-12-06 | 2008-09-12 | Aventis Pharma Sa | Indoles substitues, compositions les contenant, procede de fabrication et utilisation |
-
2005
- 2005-04-26 FR FR0504173A patent/FR2884821B1/fr not_active Expired - Fee Related
-
2006
- 2006-04-25 AR ARP060101646A patent/AR061386A1/es unknown
- 2006-04-25 PE PE2006000435A patent/PE20071420A1/es not_active Application Discontinuation
- 2006-04-26 KR KR1020077024847A patent/KR20080007229A/ko not_active Application Discontinuation
- 2006-04-26 AU AU2006239105A patent/AU2006239105A1/en not_active Withdrawn
- 2006-04-26 SI SI200630396T patent/SI1877409T1/sl unknown
- 2006-04-26 DO DO2006000096A patent/DOP2006000096A/es unknown
- 2006-04-26 DE DE602006007337T patent/DE602006007337D1/de active Active
- 2006-04-26 GT GT200600174A patent/GT200600174A/es unknown
- 2006-04-26 DK DK06743743T patent/DK1877409T3/da active
- 2006-04-26 ES ES06743743T patent/ES2328629T3/es active Active
- 2006-04-26 MX MX2007013084A patent/MX2007013084A/es active IP Right Grant
- 2006-04-26 PT PT06743743T patent/PT1877409E/pt unknown
- 2006-04-26 PL PL06743743T patent/PL1877409T3/pl unknown
- 2006-04-26 EA EA200702329A patent/EA012983B1/ru not_active IP Right Cessation
- 2006-04-26 EP EP06743743A patent/EP1877409B1/fr active Active
- 2006-04-26 WO PCT/FR2006/000925 patent/WO2006114520A2/fr active Application Filing
- 2006-04-26 BR BRPI0613161-1A patent/BRPI0613161A2/pt not_active IP Right Cessation
- 2006-04-26 PA PA20068671301A patent/PA8671301A1/es unknown
- 2006-04-26 RS RSP-2009/0400A patent/RS51136B/sr unknown
- 2006-04-26 CN CNA200680014034XA patent/CN101166739A/zh active Pending
- 2006-04-26 CA CA002605744A patent/CA2605744A1/fr not_active Abandoned
- 2006-04-26 TW TW095114907A patent/TW200718701A/zh unknown
- 2006-04-26 AT AT06743743T patent/ATE433976T1/de active
- 2006-04-26 JP JP2008508258A patent/JP2008539211A/ja active Pending
-
2007
- 2007-09-21 TN TNP2007000360A patent/TNSN07360A1/en unknown
- 2007-10-09 IL IL186523A patent/IL186523A0/en unknown
- 2007-10-11 US US11/870,640 patent/US7947706B2/en not_active Expired - Fee Related
- 2007-10-22 CR CR9463A patent/CR9463A/es not_active Application Discontinuation
- 2007-11-16 NO NO20075918A patent/NO20075918L/no not_active Application Discontinuation
- 2007-11-22 MA MA30412A patent/MA29480B1/fr unknown
-
2009
- 2009-09-16 HR HR20090494T patent/HRP20090494T1/hr unknown
- 2009-09-16 CY CY20091100957T patent/CY1109369T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RS51136B (sr) | Supstituisani pirolopiridini, kompozicije koje ih sadrže, postupak za njihovo dobijanje i upotreba | |
| RS115004A (en) | Novel thiophenylglycoside derivatives,methods for production thereof, medicaments comprising said compounds and use thereof | |
| RS52042B (sr) | Fungicidne smeše | |
| ATE433447T1 (de) | Pyrimiidinverbindungen | |
| BR0307432B1 (pt) | difluormetiltiazolilcarboxanilidas | |
| ATE338461T1 (de) | Pyrazolpyrimidinfungizide | |
| MX2007012090A (es) | Derivados sustituidos de pirazoliloxifenilo como herbicidas. | |
| UA98116C2 (ru) | Изоксазолины, композиция, их применение, способы получения и промежуточные соединения | |
| DE602004008098D1 (de) | Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren | |
| AR091405A2 (es) | Omega-carboxiaril difenil urea sustituida con fluoro y composiciones farmaceuticas que las contienen | |
| RS51454B (sr) | 5,6-dialkil-7-aminotriazolopirimidini, postupci za njihovo dobijanje, njihova primena za kontrolu patogenih gljiva, kao i sredstva koja sadrže pomenuta jedinjenja | |
| MXPA04000622A (es) | Pirazolilcarboxanilidas como funguicidas. | |
| SE0102616D0 (sv) | Novel compounds | |
| TNSN04199A1 (en) | Acyl-4-carboxyphenylurea derivatives, processes for preparing them and their use | |
| ATE296826T1 (de) | Pyrazolo(1,5)pyridinderivate | |
| MY157871A (en) | Mapk/erk kinase inhibitors | |
| NO20070089L (no) | DPP-IV inhibitorer | |
| CY1107817T1 (el) | Καρβοξαμιδια θειοφαινιου ως αναστολεις του ενζυμου ικκ-2 | |
| CY1110034T1 (el) | Παραγωγα 1,2,4,5-τετραϋδρο-3h-βενζαζεπινων, μεθοδος παρασκευης αυτων και οι φαρμακευτικες συνθεσεις που τα περιεχουν | |
| RS51661B (sr) | Novi derivati diosmetina, postupak za njihovu izradu i farmaceutske smeše koje ih sadrže | |
| ATE449069T1 (de) | Aminopropanolderivate | |
| GEP20115166B (en) | 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS | |
| RS53211B (sr) | DERIVATI PIRIDO[2,3-d]PIRIMIDINA, NJIHOVO DOBIJANJE, NJIHOVA PRIMENA U TERAPIJI | |
| SE0300092D0 (sv) | Novel compounds | |
| RS50806B (sr) | Supstituisani piroli, farmaceutski oblici koji ih sadrže, metod za njihovo dobijanje i njihova upotreba |